Smoking effects on quality of life of allergic rhinitis patients after sublingual immunotherapy

Katotomichelakis, Michael; Tripsianis, Gregory; Daniilidi, A; Cassimos, Dimitrios; Kourousis, Christos; Vogiatzaki, Theodosia; Danielides, Vassilios

doi:10.4193/rhin14.245

Cited by 3 publications

(2 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a study of 163 patients on SLIT due to allergic rhinitis, no significant difference was observed in the quality of life of smokers and nonsmokers. A study on 99 children receiving SCIT also did not reveal an impact of passive smoking [9,10]. The influence of smoking on allergic rhinitis is still unclear.…”

Section: Discussionmentioning

confidence: 97%

Smoking history is negatively associated with allergen specific immunotherapy efficacy: a retrospective analysis

Romantowski

Specjalski

Łata

et al. 2019

pdia

View full text Add to dashboard Cite

Introduction: Allergen specific immunotherapy (AIT) is the only treatment modifying the course of the disease in patients allergic to airborne allergens. It has been proven to be effective in allergic populations, however individual patients vary in terms of response to the therapy. Aim: To assess the factors that might affect the efficacy of AIT. Material and methods: Patients treated with AIT for grass pollen or house dust mites were included. The efficacy of AIT was assessed with the use of Allergy Control Score (ACS), performed before and at least 1 year after AIT. The following variables were assessed as potential risk factors for a worse response to AIT: age, gender, type of allergy, type of allergen, type of vaccine, type of AIT and smoking history. Results: The study group consisted of 145 subjects. AIT was effective in the entire group; the mean ACS results decreased from 21.14 to 14.41 points (p < 0.0001). No differences in efficacy in terms of assessed risk factors were found, except for smoking history (ACS change in the smoking group was smaller: from 21.8 to 18.1 points; p = 0.09, OR = 0.323; 95% CI: 0.11-0.88; p = 0.02). Conclusions: Smoking history may affect AIT outcomes.

show abstract

Section: Discussionmentioning

confidence: 97%

Smoking history is negatively associated with allergen specific immunotherapy efficacy: a retrospective analysis

Romantowski

Specjalski

Łata

et al. 2019

pdia

View full text Add to dashboard Cite

show abstract

“…Already for years we have ample evidence of the severe impact of allergic and non-allergic rhinitis and maybe even more rhinosinusitis on quality of life of our patients and the severe costs these diseases inflict on society (1)(2)(3)(4) .…”

Section: Rhinitis Not To Sniff Atmentioning

confidence: 99%

Rhinitis, not to sniff at

2017

Rhin

View full text Add to dashboard Cite

Already for years we have ample evidence of the severe impact of allergic and non-allergic rhinitis and maybe even more rhinosinusitis on quality of life of our patients and the severe costs these diseases inflict on society. Despite this evidence we have difficulty convincing the politicians, health insurance companies and the public that more attention, research and money is needed to prevent these diseases to occur and to further prevent the sometimes serious sequalae of the disease.

show abstract

International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis

Wise

Lin

Toskala

et al. 2018

Int Forum Allergy Rhinol

322

453

View full text Add to dashboard Cite

This critical review of the AR literature has identified several strengths; providers can be confident that treatment decisions are supported by rigorous studies. However, there are also substantial gaps in the AR literature. These knowledge gaps should be viewed as opportunities for improvement, as often the things that we teach and the medicine that we practice are not based on the best quality evidence. This document aims to highlight the strengths and weaknesses of the AR literature to identify areas for future AR research and improved understanding.

show abstract

Smoking effects on quality of life of allergic rhinitis patients after sublingual immunotherapy

Abstract: Our results suggest that smoking habits (quantity of daily smoking and duration) do not influence the success of SLIT with regards to QoL outcomes.

Cited by 3 publications

References 42 publications

Smoking history is negatively associated with allergen specific immunotherapy efficacy: a retrospective analysis

Smoking history is negatively associated with allergen specific immunotherapy efficacy: a retrospective analysis

Rhinitis, not to sniff at

International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis

Contact Info

Product

Resources

About